Search research articles
Contact Us
Filters
Showing results (881-890 of 896) with videos related to
Page
of 90
Sort By:
Nature Chemical Biology
|
April 28, 2015
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Elayne Chan-Penebre, Kristy G Kuplast, Christina R Majer, et al.
Journal of Crohn'S & Colitis
|
November 9, 2023
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib
Zhigang Liu, James L Alexander, Kai Yee Eng, et al.
Plos Genetics
|
September 9, 2011
Predisposition to cancer caused by genetic and functional defects of mammalian Atad5
Daphne W Bell, Nilabja Sikdar, Kyoo-Young Lee, et al.
Eclinicalmedicine
|
October 16, 2023
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study
Zhigang Liu, James L Alexander, Kaixing Le, et al.
Plos One
|
August 17, 2016
Assessing the Cost of Global Biodiversity and Conservation Knowledge
Diego Juffe-Bignoli, Thomas M Brooks, Stuart H M Butchart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 5, 2022
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus
Sarah Fidler, Julie Fox, Timothy Tipoe, et al.
The Lancet. HIV
|
June 21, 2021
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
John Frater, Katie J Ewer, Ane Ogbe, et al.
JCI Insight
|
February 22, 2022
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
Ane Ogbe, Matthew Pace, Mustapha Bittaye, et al.
Lancet (London, England)
|
April 2, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Katherine R W Emary, Tanya Golubchik, Parvinder K Aley, et al.
Plos One
|
November 8, 2023
A multi-taxon analysis of European Red Lists reveals major threats to biodiversity
Axel Hochkirch, Melanie Bilz, Catarina C Ferreira, et al.
Page
of 90
Search research articles
Search
Showing results (881-890 of 896) with videos related to
Sort By:
Page
of 90
Nature Chemical Biology
|
April 28, 2015
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Elayne Chan-Penebre, Kristy G Kuplast, Christina R Majer, et al.
Journal of Crohn'S & Colitis
|
November 9, 2023
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib
Zhigang Liu, James L Alexander, Kai Yee Eng, et al.
Plos Genetics
|
September 9, 2011
Predisposition to cancer caused by genetic and functional defects of mammalian Atad5
Daphne W Bell, Nilabja Sikdar, Kyoo-Young Lee, et al.
Eclinicalmedicine
|
October 16, 2023
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study
Zhigang Liu, James L Alexander, Kaixing Le, et al.
Plos One
|
August 17, 2016
Assessing the Cost of Global Biodiversity and Conservation Knowledge
Diego Juffe-Bignoli, Thomas M Brooks, Stuart H M Butchart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 5, 2022
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus
Sarah Fidler, Julie Fox, Timothy Tipoe, et al.
The Lancet. HIV
|
June 21, 2021
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
John Frater, Katie J Ewer, Ane Ogbe, et al.
JCI Insight
|
February 22, 2022
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
Ane Ogbe, Matthew Pace, Mustapha Bittaye, et al.
Lancet (London, England)
|
April 2, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Katherine R W Emary, Tanya Golubchik, Parvinder K Aley, et al.
Plos One
|
November 8, 2023
A multi-taxon analysis of European Red Lists reveals major threats to biodiversity
Axel Hochkirch, Melanie Bilz, Catarina C Ferreira, et al.
Page
of 90